P13.16.B TARGETING RBM19 TO ENHANCE RADIOTHERAPY IN GLIOBLASTOMA
Zhenyu Gong(TUM Klinikum), Yan Chen(Zhengzhou University), Kankan Cao, Zhe Wan(Peking University), Tong Liu(Jianghan University), Tao Xu(Anhui Medical University), Feng Gao(Jiangsu Province Hospital), Delong Li(Third Affiliated Hospital of Southern Medical University), H. Wang(Harvard University Press), Yunpeng Yang(Sun Yat-sen University)
Cited by 1
Related Papers
A Marker of Endotoxemia Is Associated With Obesity and Related Metabolic Disorders in Apparently Healthy Chinese
|Diabetes Care|2010|278
Green tea polyphenol EGCG suppresses lung cancer cell growth through upregulating miR-210 expression caused by stabilizing HIF-1
|Carcinogenesis|2011|257
Gut epithelial TSC1/mTOR controls RIPK3-dependent necroptosis in intestinal inflammation and cancer
|Journal of Clinical Investigation|2020|210
Deleterious Effect of CTLA4-Ig on a Treg-Dependent Transplant Model
|American Journal of Transplantation|2012|142
Efficacy, safety, and biomarker analysis of ensartinib in crizotinib-resistant, ALK-positive non-small-cell lung cancer: a multicentre, phase 2 trial
|The Lancet Respiratory Medicine|2019|139